1. Ribociclib enhances infigratinib‐induced cancer cell differentiation and delays resistance in FGFR‐driven hepatocellular carcinoma. (23rd November 2020) Authors: Prawira, Aldo; Le, Thi Bich Uyen; Vu, Thanh Chung; Huynh, Hung Journal: Liver international Issue: Volume 41:Number 3(2021) Page Start: 608 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗